Primary GBM affects elderly individuals and is genetically characterized by EGFR amplification, PTEN mutation and p16INK4a deletion [5], whereas secondary GBM has TP53 and RB2 gene mutations and develops in patients with an average age of onset of 45. This evidence concerns the gene CDKN2A and glioblastoma.